Active ingredient prescribing FAQs
From 1 February 2021 the majority of prescriptions for supply under the PBS and the RPBS must describe the medicine by active ingredient name to be eligible for subsidy.
From 1 February 2021 the majority of prescriptions for supply under the PBS and the RPBS must describe the medicine by active ingredient name to be eligible for subsidy.